|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common stock, par value (in dollars per share) | ||||||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investment securities | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid research and development | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Long-term investment securities | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Leasehold interest, net | ||||||||||||||||||||
| Equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Non-current inventories | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Loan payable - current portion | ||||||||||||||||||||
| Lease liability – current portion | ||||||||||||||||||||
| Deferred revenue - current portion | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred revenue, non-current portion | ||||||||||||||||||||
| Loan payable – non-current | ||||||||||||||||||||
| Lease liability – non-current | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, $0.001 par value per share (190,000,000 and 190,000,000 shares authorized, 159,949,330 and 158,849,596 shares issued, 153,077,784 and 155,305,953 shares outstanding at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost, 3,543,643 and 367,903 shares at December 31, 2025 and December 31, 2024 | ||||||||||||||||||||
| Treasury stock, at cost, 6,871,546 and 3,543,643 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
